Loading...
Loading...
India's linagliptin imports from UNITED STATES total $59.3M across 100 shipments from 15 foreign suppliers. BOEHRINGER INGELHEIM INTERNATIONAL leads with $58.9M in import value; the top 5 suppliers together control 99.8% of this origin. Leading Indian buyers include BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for linagliptin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

BOEHRINGER INGELHEIM INTERNATIONAL is the leading Linagliptin supplier from UNITED STATES to India, with import value of $58.9M across 22 shipments. The top 5 suppliers — BOEHRINGER INGELHEIM INTERNATIONAL, Raff & Hall Pharmacy, ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC, NewLife Medicals (USA). Inc. — collectively account for 99.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BOEHRINGER INGELHEIM INTERNATIONAL | $58.9M | 22 | 99.3% |
| 2 | Raff & Hall Pharmacy | $163.8K | 5 | 0.3% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $71.8K | 19 | 0.1% |
| 4 | GRANULES PHARMACEUTICALS INC | $44.2K | 8 | 0.1% |
| 5 | NewLife Medicals (USA). Inc. | $18.3K | 2 | 0.0% |
| 6 | NEWLIFE MEDICALS (USA). INC | $15.5K | 1 | 0.0% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC. | $14.1K | 5 | 0.0% |
| 8 | M S ESPEE BIOPHARMA FINECHEM LLC | $13.0K | 2 | 0.0% |
| 9 | PHARMA QUELLE LLC | $13.0K | 2 | 0.0% |
| 10 | AGRACE PHARMA. | $12.0K | 6 | 0.0% |
| 11 | GOOD HEALTH PHARMA SUPPLIES | $9.4K | 2 | 0.0% |
| 12 | QUANTIME WORLD INC. | $8.0K | 2 | 0.0% |
| 13 | RAFF & HALL PHARMACY | $7.9K | 1 | 0.0% |
| 14 | NEWLIFE MEDICALS (USA).INC. | $5.9K | 1 | 0.0% |
| 15 | AMSTERDAM PHARMA (APTEKA RX INC) | $5.5K | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED | $58.9M | 22 | 99.3% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $176.8K | 7 | 0.3% |
| 3 | GRANULES INDIA LIMITED | $44.2K | 8 | 0.1% |
| 4 | CIPLA LIMITED | $23.8K | 7 | 0.0% |
| 5 | WINDLAS BIOTECH LIMITED | $23.2K | 6 | 0.0% |
| 6 | HETERO LABS LIMITED | $22.1K | 4 | 0.0% |
| 7 | IPCA LABORATORIES LIMITED | $15.5K | 1 | 0.0% |
| 8 | AUROBINDO PHARMA LTD | $13.7K | 4 | 0.0% |
| 9 | AUROBINDO PHARMA LIMITED | $13.7K | 4 | 0.0% |
| 10 | EXEMED PHARMACEUTICALS | $13.0K | 2 | 0.0% |
| 11 | ALKEM LABORATORIES LIMITED | $12.8K | 4 | 0.0% |
| 12 | DR.REDDY'S LABORATORIES LTD | $12.0K | 6 | 0.0% |
| 13 | SYNOKEM PHARMACEUTICALS LIMITED | $11.0K | 4 | 0.0% |
| 14 | ABBOTT HEALTHCARE PRIVATE LIMITED | $9.4K | 2 | 0.0% |
| 15 | MICRO LABS LIMITED | $8.3K | 4 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Linagliptin suppliers from UNITED STATES to India include BOEHRINGER INGELHEIM INTERNATIONAL, Raff & Hall Pharmacy, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is BOEHRINGER INGELHEIM INTERNATIONAL with import value of $58.9M USD across 22 shipments. India imported Linagliptin worth $59.3M USD from UNITED STATES in total across 100 shipments.
India imported Linagliptin worth $59.3M USD from UNITED STATES across 100 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Linagliptin sourced from UNITED STATES include BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, GRANULES INDIA LIMITED. The largest buyer is BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED with $58.9M in imports across 22 shipments.
The total value of Linagliptin imports from UNITED STATES to India is $59.3M USD, across 100 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
100 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists